MedTrace Logo

Vitamin D Supplementation and Acute Respiratory Infection in Older Long-Term Care Residents

NCT01102374 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2017-04-21

Study results available
· View outcomes & findings →

Summary

This study will test the role of high dose vitamin D supplementation in prevention of acute respiratory infection in older nursing home residents. The investigators hypothesize that residents on high dose vitamin D supplementation will have a lower incidence of acute respiratory infection that those on standard dose vitamin D supplementation.

Conditions

  • Respiratory Infection

Interventions

DRUG

High Dose Vitamin D

Vitamin D3 100,000 IU monthly

DRUG

Standard Dose Vitamin D

Vitamin D 12,000 IU monthly

DRUG

Placebo

Placebo monthly

DIETARY_SUPPLEMENT

Usual Care

Usual care of 0-1000 IU vitamin D daily. This is present in both study arms.

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    collaborator NIH

  • The American Geriatrics Society

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Adit A Ginde, MD, MPH · University of Colorado, Denver

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2014-08-31
Completion
2016-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102374 on ClinicalTrials.gov